UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Beta-blockers in portal hypertension: new developments and controversies

Liver international, 2014-05, Vol.34 (5), p.655-667

2014

Volltextzugriff (PDF)

Baseline neutrophil‐to‐lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis

Alimentary pharmacology & therapeutics, 2019-08, Vol.50 (4), p.442-453

2019

Volltextzugriff (PDF)

Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause‐specific outcomes

Hepatology (Baltimore, Md.), 2015-08, Vol.62 (2), p.355-364

2015

Volltextzugriff (PDF)

Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis

Alimentary pharmacology & therapeutics, 2023-03, Vol.57 (5), p.454-463

2023

Volltextzugriff (PDF)

The interplay of logics and social media: An organisational field perspective

Information systems journal (Oxford, England), 2024-01, Vol.34 (1), p.80-124

2024

Volltextzugriff (PDF)

Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial

Hepatology (Baltimore, Md.), 2023-08, Vol.78 (2), p.530-539

2023

Volltextzugriff (PDF)

Selected Phase Equilibria Studies in the Al2O3-CaO-SiO2 System

Journal of the American Ceramic Society, 2016-02, Vol.99 (2), p.691-704

2016

Volltextzugriff (PDF)

Carvedilol is associated with improved survival in patients with cirrhosis: a long‐term follow‐up study

Alimentary pharmacology & therapeutics, 2021-02, Vol.53 (4), p.531-539

2021

Volltextzugriff (PDF)

Viral adventitious agent detection using laser force cytology: Intrinsic cell property changes with infection and comparison to in vitro testing

Biotechnology and bioengineering, 2022-01, Vol.119 (1), p.134-144

2022

Volltextzugriff (PDF)

Randomised clinical trial: standard of care versus early‐transjugular intrahepatic porto‐systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding

Alimentary pharmacology & therapeutics, 2020-07, Vol.52 (1), p.98-106

2020

Volltextzugriff (PDF)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland

Addiction (Abingdon, England), 2017-07, Vol.112 (7), p.1302-1314

2017

Volltextzugriff (PDF)

Editorial: when to start carvedilol in cirrhosis—time to reconsider?

Alimentary pharmacology & therapeutics, 2021-09, Vol.54 (5), p.726-727

2021

Volltextzugriff (PDF)

A transient positive association between direct‐acting antiviral therapy for hepatitis C infection and drug‐related hospitalization among people who inject drugs: Self‐controlled case‐series analysis of national data

Addiction (Abingdon, England), 2024-02, Vol.119 (2), p.369-378

2024

Volltextzugriff (PDF)

Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity

Hepatology (Baltimore, Md.), 2022-02, Vol.75 (2), p.369-378

2022

Volltextzugriff (PDF)

Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm

American journal of transplantation, 2024-05, Vol.24 (5), p.733-742

2024

Volltextzugriff (PDF)

Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed

Hepatology (Baltimore, Md.), 2009-09, Vol.50 (3), p.825-833

2009

Volltextzugriff (PDF)

Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding—long‐term follow‐up of a randomised control trial

Alimentary pharmacology & therapeutics, 2022-06, Vol.55 (12), p.1581-1587

2022

Volltextzugriff (PDF)

Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications

Basic & clinical pharmacology & toxicology, 2017-01, Vol.120 (1), p.30-37

2017

Volltextzugriff (PDF)

The changing face of liver transplantation for acute liver failure: Assessment of current status and implications for future practice

Liver transplantation, 2016-04, Vol.22 (4), p.527-535

2016

Volltextzugriff (PDF)

Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis

Journal of viral hepatitis, 2020-03, Vol.27 (3), p.270-280

2020

Volltextzugriff (PDF)

Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol‐induced hepatotoxicity

British journal of clinical pharmacology, 2012-02, Vol.73 (2), p.285-294

2012

Volltextzugriff (PDF)

Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?

The American journal of gastroenterology, 2022-09, Vol.117 (9), p.1454-1461

2022

Volltextzugriff (PDF)

Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing‐risk meta‐analysis of individual participant data

Alimentary pharmacology & therapeutics, 2024-02, Vol.59 (3), p.306-321

2024

Volltextzugriff (PDF)

General Report of Congress Question 62: What role can information and communication technology play in travelling the last mile (i.e., the greater adoption of research outputs)?

Irrigation and drainage, 2023-11, Vol.72 (5), p.1269-1273

Hayes, Peter

2023

Volltextzugriff (PDF)

Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon‐free therapies: A population‐based cohort study

Liver international, 2022-03, Vol.42 (3), p.561-574

2022

Volltextzugriff (PDF)

1 – 25 von 455

Suche als RSS-Feed

Aktive Filter

KollektionWiley-Blackwell Full Collection

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(436)
Mit Volltextzugriff
(408)

Publikationsform

Artikel
(430)
Reviews
(19)
Berichte
(6)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Beta-blockers in portal hypertension: new developments and controversies

Baseline neutrophil‐to‐lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis

Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause‐specific outcomes

Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis

The interplay of logics and social media: An organisational field perspective

Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial

Selected Phase Equilibria Studies in the Al2O3-CaO-SiO2 System

Carvedilol is associated with improved survival in patients with cirrhosis: a long‐term follow‐up study

Viral adventitious agent detection using laser force cytology: Intrinsic cell property changes with infection and comparison to in vitro testing

Randomised clinical trial: standard of care versus early‐transjugular intrahepatic porto‐systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland

Editorial: when to start carvedilol in cirrhosis—time to reconsider?

A transient positive association between direct‐acting antiviral therapy for hepatitis C infection and drug‐related hospitalization among people who inject drugs: Self‐controlled case‐series analysis of national data

Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity

Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm

Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed

Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding—long‐term follow‐up of a randomised control trial

Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications

The changing face of liver transplantation for acute liver failure: Assessment of current status and implications for future practice

Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis

Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol‐induced hepatotoxicity

Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?

Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing‐risk meta‐analysis of individual participant data

General Report of Congress Question 62: What role can information and communication technology play in travelling the last mile (i.e., the greater adoption of research outputs)?

Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon‐free therapies: A population‐based cohort study

Aktive Filter

Suchergebnisse filtern